Certified by Founder Lodge
Clade Therapeutics
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $87,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 03 ,2021 | Series A | $87,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Voio | $8,600,000 | (Nov 21, 2025)
Stuut | $29,500,000 | (Nov 21, 2025)
Made Card | $8,000,000 | (Nov 21, 2025)
Revenium | $13,500,000 | (Nov 21, 2025)
EQORE | $1,700,000 | (Nov 21, 2025)
